Leuprolide Withdrawn Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02811809Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer
NCT00244920Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
NCT00771017Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer